A federal docket that says “dismissed,” a refiling in Nevada state court, a claims-made deal with no cap, a voucher option and five opt-outs out of 835,159. Almost every procedural feature that confuses people about class actions appears in this one case.
Build a focused intake file documenting product use, injury, timing, damages, and authority to request records.
Learn how to test a mass-tort claim for eligibility, causation evidence, record needs, and urgent deadline risks.
A defense checklist clarifies MDL fit, causation proof, expert timing, and case-specific deadline risks.
Learn how individual facts shape mass-tort eligibility, causation evidence, and the deadlines that may control a claim.
Learn how legal fees, shared litigation costs, Medicare recovery, and taxes may reduce a mass tort settlement.
See which mass-arbitration delays courts rejected, why remedies differed, and what September’s FINRA notice covers.
Learn how court orders, claim vetting, case selection, and dismissals can move a mass tort bellwether date.
Track the Depo-Provera settlement, pending drug MDLs, an Injectafer warning, and two September recalls.
Build a source-linked medical timeline that identifies missing records without turning uncertainty into assumed facts.